Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan;36(1):196-199.
doi: 10.1007/s11606-020-06330-y. Epub 2020 Oct 27.

Making Narrative Statements to Describe Treatment Effects

Affiliations

Making Narrative Statements to Describe Treatment Effects

M Hassan Murad et al. J Gen Intern Med. 2021 Jan.

Abstract

Accurately describing treatment effects using plain language and narrative statements is a critical step in communicating research findings to end users. However, the process of developing these narratives has not been historically guided by a specific framework. The Agency for Healthcare Research and Quality Evidence-based Practice Center Program developed guidance for narrative summaries of treatment effects that identifies five constructs. We explicitly identify these constructs to facilitate developing narrative statements: (1) direction of effect, (2) size of effect, (3) clinical importance, (4) statistical significance, and (5) strength or certainty of evidence. These constructs clearly overlap. It may not always be feasible to address all five constructs. Based on context and intended audience, investigators can determine which constructs will be most important to address in narrative statements.

Keywords: dissemination; evidence-based medicine; plain language summary; statistics and numerical data; systematic reviews.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they do not have a conflict of interest.

Figures

Figure 1
Figure 1
Overlapping constructs that systematic reviewers can use when developing narrative statements about treatment effects.

References

    1. Tricco AC, Cardoso R, Thomas SM, Motiwala S, Sullivan S, Kealey MR, et al. Barriers and facilitators to uptake of systematic reviews by policy makers and health care managers: a scoping review. Implement Sci. 2015;11(1):4. doi: 10.1186/s13012-016-0370-1. - DOI - PMC - PubMed
    1. Marquez C, Johnson AM, Jassemi S, Park J, Moore JE, Blaine C, et al. Enhancing the uptake of systematic reviews of effects: what is the best format for health care managers and policy-makers? A mixed-methods study. Implement Sci. 2018;13(1):84. doi: 10.1186/s13012-018-0779-9. - DOI - PMC - PubMed
    1. Wasserstein RL, Lazar NA. The ASA statement on p-values: context, process, and purpose. Am Stat. 2016;70(2).
    1. Cochrane Effective Practice and Organization of Care (EPOC). Reporting the effects of an intervention in EPOC reviews. EPOC Resources for Review Authors. 2018. https://epoc.cochrane.org/sites/epoc.cochrane.org/files/public/uploads/R.... Accessed 23 Oct 2020.
    1. Santesso N, Glenton C, Dahm P, Garner P, Akl EA, Alper B, et al. GRADE guidelines 26: Informative statements to communicate the findings of systematic reviews of interventions. J Clin Epidemiol. 2020;119:126–35. doi: 10.1016/j.jclinepi.2019.10.014. - DOI - PubMed

Publication types

LinkOut - more resources